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Figure 2. Thymidylate Synthase Cycle showing 
the production of thymidylate, dTMP (Lehninger). 
 
Figure 1: Proposed mechanism of SHMT catalyzing the tetrahydrofolate-
dependent conversion of serine to glycine (Schirch, 2005).  
Overexpression and Partial Purification of Serine Hydroxymethyltransferase 
I.  INTRODUCTION 
Serine hydroxymethyltransferase, SHMT, is a vital enzyme involved in the 
biosynthesis of pyrimidine nucleotides.  SHMT is a pyridoxyl-5’-phosphate (PLP)-
dependent enzyme and it generates one-carbon fragments for the biosynthesis of small 
molecules such as purines, thymidylate, methionine, and choline (Schirch, 2005). The 
enzyme catalyzes the 
tetrahydrofolate-dependent 
conversion of serine to glycine.  
Geometric structural studies have 
led to a proposed retroaldol 
mechanism of this conversion (Figure 1), which involves a nucleophilic attack by N5 of 
tetrahydrofolate on serine C3 breaking the C3—C2-
bond of serine (Schirch, 2005).     
The enzyme is part of the thymidylate 
synthase cycle (Figure 2), which generates 
nucleotides needed for DNA synthesis of growing 
cells.  SHMT converts serine and tetrahydrofolate 
to glycine and N5, N10-methylenetetrahydofolate.  A 
one-carbon unit from N5, N10-
methylenetetrahydrofolate is transferred to 
deoxyuridine monophosphate, dUMP, to produce 
thymidylate, dTMP (Lehninger).   
 During the S Phase of the cell cycle, DNA is replicated to produce a second copy 
of the DNA,    one for each daughter cell.  The enzyme that synthesizes DNA, DNA 
polymerase, uses deoxynucleotides to produce a copy of the original DNA template 
strand.  The four deoxynucleotides used for DNA synthesis include deoxycytidylate, 
deoxyadenylate, deoxyguanylate, and thymidylate (Lehninger).   If a cell is incapable of 
copying its DNA, it is unable to divide.  Since SHMT is needed for the biosynthesis of 
thymidylate, it suggests that inhibitors of SHMT could potentially serve as anticancer 
drugs in prohibiting the growth of cancer cells.  
Extensive research has gone into the other two enzymes in the thymidylate 
synthase cycle, dihydrofolate reductase (DHFR) and thymidylate synthase (TS), as 
possible anticancer targets.  Methotrexate is an anticancer antifolate drug from the 1950s 
that targets DHFR (McGuire, 2003).  Methotrexate is still used today, and because of its 
utility and safety, attention has been put into finding more anticancer antifolates 
(McGuire, 2003).  A recent study showed how 2-hydroxyoleic acid (HOA) repressed the 
expression of DHFR.  When cancer cells were treated with HOA, cell cycle arrest or 
apoptosis resulted, most likely from the impairment of DNA synthesis (Llado, 2009).  A 
lot of attention has also been paid to inhibitors of thymidylate synthase.  Fluorouracil is a 
chemotherapy drug that inhibits thymidylate synthase.  It has been around for a few 
decades and its primary use is a chemotherapy agent for colorectal and pancreatic cancer.  
A recent finding showed how histone deacetylase inhibitors significantly down regulate 
thymidylate synthase gene expression in colon cancer cells (Fazzone, 2009).  Several 
studies have been conducted to find inhibitors of DHFR and TS but little effort has been 
invested in SHMT.   
 In order to characterize the 
activity and other properties of SHMT, it 
first has to be overexpressed and purified from E. coli.  A particular colony of E. coli 
cells, SHMT SL75 BL21, contains a plasmid which encodes for the human SHMT gene.  
For the gene to be expressed, its DNA sequence has to be copied through the process of 
transcription.  A repressor protein is bound to the DNA to block RNA polymerase from 
binding to the DNA strand and transcribing mRNA.  An inducer is needed to bind to the 
repressor, causing a conformational change in the repressor so that it leaves the DNA 
strand.  Arabinose is a five carbon monosaccharide that acts as an inducer, allowing for 
the start of SHMT gene expression (Wikipedia).   
To purify the enzyme, two techniques are used; protein precipitation and fast 
protein liquid chromatography (FPLC).  Protein precipitation, or “salting out”, is a 
common method used to separate proteins based on their solubility.  The addition of a 
neutral salt, such as ammonium sulfate, increases the salt concentration of a solution.  
This causes the water to interact more with the salt ions and less with the solvation layer 
around the proteins.  The proteins that express hydrophobic patches aggregate with each 
other and precipitate out of solution.   
 FPLC is used to purify SHMT by ion exchange.  The isoelectric point, pI, of a 
protein is the pH where the enzyme has no net electrical charge.  At a pH below the 
Figure 3. Arabinose binds to the repressor, allowing RNA 
Polymerase to attach to the Operator so that gene expression 
of SHMT can begin.   
 protein’s pI, it will carry a net positive charge and will bind to a negatively charged 
column whereas negatively charged proteins will not bind.  SHMT has a pI of about 8.3 
(Nirmalan, 2007).  A pH of about 7.9 is used for the FPLC column so that SHMT will 
have a net positive charge.  The protein will be eluted by changing the ionic strength of 
the column.   
 After fractions are collected from FPLC, the activity of SHMT in each fraction 
can be traced by absorbance spectroscopy.  SHMT from other sources has been known to 
catalyze a side reaction of allo-threonine to acetaldehyde.  The enzyme alcohol 
dehydrogenase then converts acetaldehyde and NADH to ethanol and NAD+.  NADH has 
a strong absorbance at 340nm so when it’s oxidized to NAD+, the absorbance decreases 
over time. 
 
 
 
 
 
 
 
 
 
 
 
 
 II.  METHODS AND MATERIALS 
Small Scale Overexpression 
Overnight cultures were prepared with LB, 0.034mg/mL chloramphenicol 
(CAM), 0.05mg/mL ampicillin (AMP), and SHMT BL21 SL75 cells.  The cultures 
incubated on a shaker overnight at 37˚C.  Flasks containing LB, CAM, and AMP were 
inoculated with 1mL of the overnight culture.  The flasks were placed on a shaker at 37˚C 
and the absorbance of the cultures was measured periodically using the Ocean Optics 
Spectrophotometer at 600nm.  When the OD600 reached 0.6, an inducer was added to the 
flask; either 1mM IPTG or various concentrations of arabinose, ranging from 0.002% to 
1%.  The cells were placed on a shaker at 37˚C for four hours.  The cultures were 
centrifuged for fifteen minutes at 3200rpm, the supernatant was poured off, and the cells 
were stored in the -80˚C freezer until purification.  
 
Purification Prep 
The cells were removed from the -80˚C freezer and thawed over ice.  They were 
resuspended in cold Tris pH 7.4 buffer with 0.5mg/mL lysozyme.  The cells were 
sonicated while on ice, using a pattern of 1.5 seconds of pulse followed by 10 seconds of 
no pulse for a total of thirty pulses.  The samples were centrifuged for 20 minutes at 4˚C 
and a rate of 10,000rpm.  The cell free extract was saved for purification.   
 
Purification by Nickel Column 
The nickel column was prepared by equilibrating with 15mL of equilibration 
buffer (20mM Tris pH 7.4, 10mM imidazole, 300mM NaCl).  20uL of the cell free 
 extract was saved for gel analysis and the rest was loaded onto the column. The column 
was washed with 20 column volumes of equilibration buffer and the first and last mL 
fractions from the wash were collected.  About 10 column volumes of elution buffer 
(20mM Tris pH 7.4, 500mM imidazole) was run through the column, while collecting 
1mL fractions of the elution.  The column was washed with 10 more column volumes of 
the elution buffer followed by 20 column volumes of equilibration buffer for storing.  
The absorbance of each fraction was measured at 280nm to find the most concentrated 
fractions.  The selected fractions were analyzed by PAGE gel analysis.  
 
Activity Assay 
Into each of two cuvettes, 25mM sodium phosphate, 0.5mM allo-threonine, 
0.01mM PLP and 800uL of water was added.  40uL of cell free extract, either induced 
with 1% arabinose or uninduced, was added to each cuvette.  The cuvettes were covered 
and allowed to sit overnight at room temperature.  The next day, the absorbance of each 
cuvette was measured at 340nm immediately after the addition of 0.1mM NADH and 
15U/mL of alcohol dehydrogenase.  The absorbance at 340nm was collected for three 
minutes.  This was repeated for each cuvette.   
 
Determination of Ammonium Sulfate Precipitation 
Cell free extract was combined with various concentrations of ammonium sulfate 
(AS); 30%, 45%, 55%, 65%, 75%, and 90%.  The mixtures were centrifuged for 20 
minutes at 4˚C at a rate of 10,000rpm to separate out the precipitates.  A sample of 
supernatant and pellet was removed and saved from each of the AS cuts.  The samples 
 were run on gels for analysis.  Three of the samples, 30%, 65%, and 75% cuts, were 
tested for their activity using the same assay from above.   
 
Fast Protein Liquid Chromatography (FPLC) 
Cells were overexpressed with 1% arabinose and were purified by ammonium 
sulfate precipitation.  After a 30% cut, the 70% AS ppt was resuspeneded in 20mM Tris 
pH 7.9 buffer.  The FLPC column was stored in 50% water and 50% of 20% ethanol.  
The column was washed with about 40 column volumes of water before use to remove 
the ethanol, then it was equilibrated with the Tris buffer.  Two pumps were connected to 
the column; Pump A was 20mM Tris pH 7.9 and Pump B was 20mM Tris 1M NaCl pH 
7.9.  After the protein was injected onto the column, the FPLC ran a gradient of 100% 
Pump A: 0% Pump B to 0% Pump A: 100% Pump B.  1mL fractions were collected and 
their absorbance was measured at 280nm.  The highest concentrated fractions were saved 
for gel electrophoresis.   
 
 
 
 
 
 
 
 
 
  
Figure 1: SDS-PAGE gel of cell free extract of SHMT SL75 BL21 cells with and without induction 
using 1M IPTG.  Lane contents:  1. 1mM IPTG, diluted; 2. 1 mM IPTG; 3. Protein standard; 4. 
0mM IPTG, diluted; 5. 0mM IPTG; 6. 1mM IPTG, diluted; 7. 1mM IPTG; 8. 0mM IPTG, diluted; 
9. 0mM IPTG; 10. 1mM IPTG; 11. 0mM IPTG.  Lanes 1,2,4,5,10, and 11 were soluble fractions 
and lanes 6 through 9 were insoluble. 
III.  RESULTS 
Overexpression 
Overexpression conditions for SHMT were explored.  It was assumed IPTG would 
induce production of the protein. Numerous trials showed results similar to Figure 1.  
 
 
 
 
 
 
 
 
 
 
 
No expression of SHMT was observed when using IPTG as the inducer. Numerous trials 
were performed using arabinose instead of IPTG.  In order to determine the ideal amount 
of arabinose to use, an overexpression was performed using a range of arabinose 
concentrations from 0% to 1% and can be seen in Figure 2.     
 
 
 
 
 
Lanes:            1        2       3        4       5        6       7      8       9     
  
 
 
 
 
 
 
 
 
 
 
 
Low levels of overexpression are observed in lanes 4 and 5 with 0.5% and 1% arabinose, 
respectively.   
 
Purification 
Protein purification by a nickel column was performed with the idea that the SHMT gene 
on the plasmid in the E-coli cells also encodes for a his-tag.  If this is the case, the his-tag 
would allow for SHMT to stick to the nickel column as other protein washed through, 
since histidine has a high affinity for metal ions such as nickel.    
 
 
 
Lanes:      1     2      3     4      5    6    7     8     9     10   11 
Figure 2: SDS-PAGE gel of cell free extract of SHMT SL75 BL21 cells induced with various 
concentrations of arabinose.  Lane contents: 1. 0% arabinose; 2. 0.002% arabinose; 3. 0.02% 
arabinose; 4. 0.5% arabinose; 5. 1.0 % arabinose; 6. 0% arabinose; 7. 0.002% arabinose; 8. 0.02% 
arabinose; 9. 0.5% arabinose; 10. 1.0% arabinose; 11. Protein standard 
 
  
  
 
 
 
 
 
 
 
 
 
 
 
Optimal results for the purification of SHMT by a nickel column would show only one 
band of protein in the elution fraction, corresponding to SHMT.  Multiple bands can be 
seen in lane 10 so it was determined that purification by nickel column would not be used 
to purify the protein from SHMT SL75 BL21 cells.  
 
Activity Assay  
Figure 4: Coupled reaction of SHMT and alcohol dehydrogenase (ADH).  
 
 
 
 
 
 
Lanes: 1       2       3        4        5      6     7     8      9      10     11    12     
Figure 3: SDS-PAGE gel of nickel column fractions from SHMT SL75 BL21 cells with and without 
induction using 1% arabinose.  Lane Contents: 1. Cell free extract; 2. Load; 3. First wash; 4. Last wash; 
5. 2ndmL of elution; 6. 4thmL of elution; 7. Protein standard; 8. Cell free extract; 9. Concentrated 
elution; 10. 2ndmL of elution; 11. 4thmL of elution; 12. Load; 13. First wash; 14. Last wash.  Lanes 1-6 
refer to the cells that were not induced with arabinose and Lanes 8-14 were induced with 1%.   
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The coupled reaction shown above will be used to observe the activity of SHMT.  If 
human SHMT actively converts allo-threonine to acetaldehyde, which is a known side 
reaction catalyzed by SHMT from other sources, then the addition of NADH and alcohol 
dehydrogenase (ADH) will oxidize NADH to NAD+.  This can be measured by 
absorbance spectroscopy because NADH absorbs at 340nm, whereas NAD+ does not. 
 
 
 
 
 
 
 
 
 
 
 
SHMT from several sources has been shown to catalyze the side reaction with allo-
threonine.  Figure 5 shows that human SHMT is also capable of catalyzing the same 
reaction.  
 
 
 
Figure 5: The activity of SHMT with allo-threonine observed by following the absorbance of NADH, 
which is oxidized by ADH over time.  SHMT SL75 BL21 cells had been overexpressed with 1% 
arabinose.  40µL cell free extract was added to 500mM sodium phosphate, 33mM allo-threonine, 5mM 
PLP, 50 mM NADH, 1500 u/mL ADH, and 800µL water.  All the components except for NADH and 
ADH were allowed to sit overnight.  The absorbance was measured to be 1.41 after the addition of 
50mM NADH and before the addition of ADH.  
 
 Lanes:  1     2     3      4      5      6       7                Lanes:   1          2       3       4       5        6     
Determination of Ammonium Sulfate Precipitation 
In order to purify SHMT by salt precipitation, it’s important to know at which salt  
concentration the protein will precipitate and salt out.  A saturated ammonium sulfate 
solution was added to cell free extract and cuts were made at 30%, 45%, 55%, 65%, 75%, 
and 90% ammonium sulfate.  The insoluble pellets as well as the soluble fractions were 
run on a gel. 
 
 
 
The 30% AS pellet and the 65% and 75% AS solutions were saved for analysis by an 
activity assay.  The coupled reaction with alcohol dehydrogenase was used and the 
absorbance of NADH at 340nm was measured over time for each fraction.   
 
 
 
 
 
      
Figure 6: SDS-PAGE gels of SHMT SL75 BL21 cells overexpressed with 1% arabinose and purified by 
ammonium sulfate.  Lane contents: (A) 1. Cell free extract; 2. Protein standard; 3. 30% pellet; 4. 45% 
solution; 5. 45% pellet; 6. 45% pellet, diluted; 7. 55% solution. (B) 1. 55% pellet; 2. 65% pellet; 3. 65% 
pellet, diluted; 4. 65% solution; 5. 75% solution; 6. 75% pellet; 7. Protein standard; 8. 75% pellet, diluted; 
9. 95% solution. 
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Bef
ore alcohol dehydrogenase was added, the absorbances at 340nm were 0.550, 0.667, and 
0.582 for the 30%, 65%, and 75% fractions, respectively.  From this figure, it was 
concluded that a 30% ammonium sulfate cut would remove unwanted proteins and a 70% 
cut would contain SHMT. 
 
Fast Protein Liquid Chromatography 
SHMT SL75 BL21 cells were overexpressed with 1% arabinose and were purified by salt 
precipitation.  A 30% AS cut was made followed by a 70% cut.  The precipitate from the 
70% cut was resuspended in 20mM Tris buffer and was further purified by FPLC.  
Fractions were collected from the FPLC and their absorbance was measured at 280nm.  
Two peaks were observed where protein was eluted from the column, seen in Figure 8 
below.   
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Figure 7:  Activity Assay for Protein Precipitation Fractions.  40µL of the ammonium sulfate 
fractions were added to 500mM sodium phosphate, 33mM allo-threonine, 5mM PLP, 50 mM 
NADH, 1500 u/mL ADH, and 800µL water. 
 Figure 8: Absorbance of FPLC fractions at 280nm 
 
 
 
 
 
 
 
 
Fractions 2, 3, 4, 25, 26, 27, 28, 29, and 35 from the FPLC run were analyzed by gel 
electrophoresis shown in Figure 9 below.     
 
 
 
 
 
 
 
 
 
The same fractions analyzed by gel electrophoresis were also analyzed using the activity 
assay with allo-threonine which is presented below in Figure 10.   
 
 
 
Lanes:          1       2        3     4    5       6       7       8      
9    10 
Figure 9: SDS-PAGE gel of SHMT SL75 BL21 cells induced with 1% arabinose and 
purified by ammonium sulfate precipitation and FPLC.  Lane Contents: 1. Fraction #2; 2. #3; 
3. #4; 4. Protein standard; 5. #25; 6. #26; 7. #27; 8. #28; 9. #29; 10. #35. 
 
  
 
 
 
 
 
 
 
 
 
A decrease in absorbance of NADH is not observed for any of the FPLC fractions 
suggesting that SHMT was never eluted from the FPLC column.   
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Figure 10:  The activity of SHMT with allo-threonine observed by following the absorbance of 
NADH.  40µL of the FPLC fractions were added to 500mM sodium phosphate, 33mM 
allothreonine, 5mM PLP, 50 mM NADH, 1500 u/mL ADH, and 800µL water.  
 IV.  DISCUSSION 
 The goal of this experiment was to overexpress and purify human SHMT from E. 
coli.  SHMT was successfully overexpressed from SHMT SL75 BL21 cells using 
arabinose as the inducer.   Appropriate ammonium sulfate concentrations were 
determined for the initial purification of the protein.  In addition to this, the coupled side 
reaction with allo-threonine was established, as it had not been studied using the human 
enzyme.   
Through multiple overexpression trials, it was observed that 1% arabinose 
induces SHMT protein expression, whereas IPTG does not.  It had been assumed that 
IPTG would induce SHMT expression, but after analyzing SDS-PAGE results from 
numerous overexpressions, similar to Figure 1, it was concluded that IPTG did not induce 
SHMT expression.  The molecular weight of human SHMT is approximately 53 kDa.  
The protein standard used for gel electrophoresis has proteins with known molecular 
weights of 113, 91, 49, 35.1, and 28.4 kDa.  Looking at the protein standard in lane 3 of 
Figure 1, the third band from the top of the gel corresponds to the protein that has a 
molecular weight of 49 kDa.   If SHMT was successfully overexpressed when using 
IPTG, a band slightly above the 49 kDa marker would be seen in the lanes induced with 
1mM IPTG and absent in control lanes that lacked IPTG.  This is not observed in the 
Figure 1 gel, suggesting that IPTG did not lead to the overexpression of SHMT.   
 Similar overexpressions were carried out using concentrations of arabinose in 
place of IPTG and overexpression was observed.  Through a trial that varied the 
concentration of arabinose, it was concluded that a 1% arabinose concentration is 
optimal.  This can be observed in lanes 4 and 5 in Figure 2, which have concentrations of 
0.5% and 1.0% arabinose, respectively.  Looking at these lanes, there is a band that can 
 be seen around the predicted SHMT band location of approximately 50 kDa.  This band 
is absent in the lanes that either contained low concentrations of arabinose or lacked 
arabinose, suggesting that a concentration of 0.5% or higher of arabinose will 
overexpress human SHMT from the E. coli cells.    
 The cell free extract refers to the mixture that contains the proteins after insoluble 
unwanted cell debris was removed.  Looking at the gel in Figure 3, lane 1 is the cell free 
extract from E. coli cells that were not induced with arabinose, and lane 8 is the cell free 
extract from E. coli cells that were induced with 1% arabinose.  A band that is slightly 
above the 49kDa marker in lane 8 but which is absent in lane 1 further shows how 1% 
arabinose successfully overexpresses the SHMT protein.  For the nickel column 
purification, both of the cell free extracts were loaded onto separate nickel columns.  The 
columns were washed with buffer to remove all the proteins that didn’t bind to the nickel.  
Imidazole, a histidine analog, was used to elute the protein from the column and fractions 
were collected.  Lane 10 in Figure 3 is a fraction of the elution that was collected from 
the nickel column, which had been loaded with the induced cell free extract.  Ideally, 
only one band would be seen in this lane corresponding to SHMT.  However, lane 10 
shows a few bands which suggests that purification of the protein from SHMT SL75 
BL21 cells through nickel column is ineffective.   
 SHMT activity was observed when the coupled reaction assay, shown in Figure 4, 
was performed using cell free extract from cells induced with 1% arabinose.  Other 
sources of SHMT have been shown to catalyze this side reaction, but the assay performed 
in our laboratory is the first time that human SHMT has been shown to catalyze this side 
reaction. The absorbance of NADH decreased over time after alcohol dehydrogenase was 
 added to the cuvette, as seen in Figure 5.  It can be inferred from this graph that SHMT 
actively converted allo-threonine to acetaldehyde.  Also, before the addition of alcohol 
dehydrogenase, the absorbance of the cuvette at 340nm read 1.41.  Looking at the graph 
when the absorbance was first collected, the absorbance reads only 0.71.  This suggests 
that in the few seconds after alcohol dehydrogenase was added and before the “start” 
button was pressed, the alcohol dehydrogenase had already oxidized a large portion of the 
NADH.  This would need to be repeated using a control that was uninduced because if 
the control also showed a decrease in the absorbance at 340nm, then it could be possible 
that there is an E-coli enzyme that is capable of converting allo-threonine to 
acetaldehyde.  However, it is not possible to rule out the possibility that the observed 
activity is due to another E-coli enzyme without a control.   
 From ammonium sulfate precipitation trials, it was concluded that for the optimal 
purification of SHMT, a 30% ammonium sulfate cut would remove unwanted proteins 
and a 70% cut would contain SHMT.  Figure 6 shows the two gels from an ammonium 
sulfate precipitation experiment.  The desired SHMT band is not clearly noticeable in any 
of the lanes until lane 6 of the second gel which is the 75% AS cut.  The band might also 
be seen in lane 4 of the same gel which is the 65% AS solution, but it’s difficult to see 
here.  To further determine the correct amount of ammonium sulfate needed to precipitate 
SHMT from solution, an activity assay was performed using the 65% and 75% AS 
solutions and the 30% AS pellet.  The 30% pellet was used as a control in order to show 
that very little or no SHMT is present in that particular cut.  This is shown in Figure 7, as 
the absorbance at 340nm for the 30% cut decreases very slightly and mostly stays 
constant over time.  The other two lines in this graph have a drastic decrease in 
 absorbance suggesting that there are high levels of SHMT in these fractions.  From this 
graph, it was determined that for the purification of SHMT, a 30% ammonium sulfate cut 
would remove unwanted proteins and a 70% cut would contain SHMT.   
 The results from the FPLC indicate that SHMT was not further purified by this 
technique.  None of the fractions contained any trace of SHMT, as demonstrated by the 
activity assay, suggesting that the protein was never successfully loaded onto the column.  
The A280 of the FPLC fractions was measured in order to determine which fractions had 
the highest protein concentration, assuming that at least one would contain SHMT.  
Figure 8 has two strong peaks that show when protein was removed from the column.  By 
looking at this figure, it seems that the initial peak likely contains proteins that were 
negatively charged and didn’t bind to the column.  The second peak was assumed to 
contain SHMT from when the protein was eluted from the column.  Fractions involved in 
these two peaks were saved for further analysis and were run on a gel.  The gel in Figure 
9 is difficult to see but it could be possible the lanes 2 or 6, fraction #3 and #26 
respectively, show the SHMT band.  To more accurately determine which fraction 
contained SHMT, the coupled activity assay was performed.  However, as seen in Figure 
10, none of the fractions had a decrease in absorbance at 340nm.  This suggests that none 
of the fractions contained SHMT.  There could be a few different explanations for this.  
First, it’s possible that the SHMT eluted from the column was too dilute to show a 
decrease in absorbance at 340nm.  Second, there could have been a mistake during the 
particular overexpression used for the FPLC column resulting in no SHMT be expressed.  
Also, it’s very likely that this could be due to the operation of the pump or operator error 
suggesting that the protein was never loaded onto the column.  Troubleshooting along 
 with additional FPLC experiments should be done in order to obtain better results for the 
purification of SHMT.   
 
V.  CONCLUSION 
Despite the results from the FPLC, several accomplishments for the 
overexpression and purification of human SHMT were met.  First, arabinose was 
identified as the inducer for the expression of SHMT instead of IPTG, and a 1% 
arabinose concentration was determined to be optimal.  In addition, appropriate 
ammonium sulfate concentrations for the initial purification of SHMT were identified.  
Finally, the coupled assay with allo-threonine was established, and it was demonstrated 
that human SHMT can catalyze this side reaction.  
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